Therapeutic Classification: antiplatelet agents
Pharmacologic Classification: protease-activated receptor-1 (PAR-1) antagonists
REMS
Absorption: Completely absorbed (100%) following oral administration.
Distribution: Unknown.
Protein Binding: >99%.
Half-Life: Effective half-life: 34 days, terminal elimination half-life: 8 days (range 513 days, similar for M20).
Contraindicated in:
Use Cautiously in:
Drug-drug:
Drug-Natural Products: